Bayer sells stake in Agfa-Gevaert
Leverkusen – Bayer sells its remaining stake of 30 percent in the Belgian imaging technologies company Agfa-Gevaert N.V. to the investment bank Goldman Sachs. This transaction will result in a tax-free gain for Bayer of roughly Euro 200 million. The Bank plans to resell this stake which represents 42 million shares to financial investors.
"The sale of our financial investment in Agfa is in line with our goal of further enhancing the Bayer Group's structure," said Bayer's Management Board Chairman Werner Wenning. "We will use the proceeds to reduce financial debt, thereby increasing the scope for expanding our core businesses. The block sale is market-neutral and therefore the best solution for Agfa's stockholders."
Bayer floated its former subsidiary Agfa on the stock exchange in 1999 for strategic reasons, retaining 30 percent of the shares as a temporary financial investment.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
